Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
DLHIX vs IXJ
Shared holdings
25
DLHIX covered by IXJ
39.18%
IXJ covered by DLHIX
39.18%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
DLHIX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| UCB SA | 5.91% | |
| REGENERON PHARMACEUTICALS INC | 5.47% | |
| PFIZER INC | 4.84% | |
| GILEAD SCIENCES INC | 4.41% | |
| ABBVIE INC | 4.10% | |
| MERCK & CO | 3.90% | |
| ASTRAZENECA PLC | 3.87% | |
| CHUGAI PHARMA CO | 3.74% | |
| LILLY ELI and CO | 3.60% | |
| ROCHE HOLDING AG | 3.31% | |
| UNITEDHEALTH GRP | 2.85% | |
| ELEVANCE HEALTH INC | 2.78% | |
| AMGEN INC | 2.49% | |
| VIATRIS INC | 2.38% | |
| BOSTON SCIENTIFIC CORP | 2.36% | |
| HALOZYME THERAPEUTICS INC | 2.14% | |
| Sanofi SA | 1.75% | |
| VERTEX PHARMACEUTICALS INC | 1.68% | |
| ILLUMINA INC | 1.67% | |
| VIKING THERAPEUTICS INC | 1.62% | |
| ALKERMES PLC | 1.54% | |
| ALNYLAM PHARMACEUTICALS INC | 1.50% | |
| FEDERAL NATIONAL MORTGAGE ASSOCIATION | 1.42% | |
| ROIVANT SCIENCES LTD | 1.41% | |
| NEUROCRINE BIOSCIENCES INC | 1.39% | |
| COGENT BIOSCIENCES INC | 1.33% | |
| ARCUS BIOSCIENCES INC | 1.23% | |
| INCYTE CORP | 1.13% | |
| ZIMMER BIOMET HO | 1.09% | |
| TARSUS PHARMACEUTICALS INC | 1.06% | |
| FREDDIE MAC | 1.01% | |
| QUEST DIAGNOSTICS INC | 0.89% | |
| BIOMARIN PHARMACEUTICAL INC | 0.85% | |
| CVS HEALTH CORP | 0.81% | |
| MONEYMKT | 0.81% | |
| BlackRock Liquidity FedFund - Institutional Class | 0.81% | |
| MSILF-GOVT-INS | 0.81% | |
| MONEYMKT | 0.81% | |
| ANAPTYSBIO INC | 0.78% | |
| BIOGEN INC | 0.77% | |
| Abivax SA SPONSORED ADS | 0.75% | |
| STRYKER CORP | 0.74% | |
| JOHNSON&JOHNSON | 0.74% | |
| VIR BIOTECHNOLOGY INC | 0.67% | |
| GRAIL INC | 0.66% | |
| RIGEL PHARMACEUTICALS INC | 0.65% | |
| UNIQURE N.V. | 0.64% | |
| SYNDAX PHARMACEUTICALS INC | 0.63% | |
| MADRIGAL PHARMACEUTICALS INC | 0.55% | |
| THERAVANCE BIOPHARMA INC | 0.51% |
IXJ (March 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 9.42% | |
| JOHNSON&JOHNSON | 7.61% | |
| ABBVIE INC | 4.97% | |
| ASTRAZENECA PLC | 4.01% | |
| MERCK & CO | 3.95% | |
| Novartis AG (Registered) | 3.86% | |
| ROCHE HOLDING AG | 3.71% | |
| UNITEDHEALTH GRP | 3.24% | |
| AMGEN INC | 2.51% | |
| THERMO FISHER SCIENTIFIC INC | 2.44% | |
| ABBOTT LABS | 2.36% | |
| GILEAD SCIENCES INC | 2.29% | |
| INTUITIVE SURGICAL INC | 2.17% | |
| PFIZER INC | 2.11% | |
| BRISTOL-MYERS SQUIBB CO | 1.63% | |
| DANAHER CORP | 1.58% | |
| NOVO NORDISK-B | 1.54% | |
| VERTEX PHARMACEUTICALS INC | 1.50% | |
| STRYKER CORP | 1.50% | |
| GSK PLC | 1.49% | |
| MEDTRONIC PLC | 1.47% | |
| MCKESSON CORP | 1.40% | |
| Sanofi SA | 1.37% | |
| BOSTON SCIENTIFIC CORP | 1.23% | |
| CVS HEALTH CORP | 1.21% | |
| REGENERON PHARMACEUTICALS INC | 1.03% | |
| HCA HEALTHCARE INC | 0.98% | |
| THE CIGNA GROUP | 0.93% | |
| ESSILORLUXOTTICA | 0.90% | |
| ELEVANCE HEALTH INC | 0.85% | |
| CENCORA INC | 0.81% | |
| TAKEDA PHARMACEU | 0.78% | |
| HOYA CORP | 0.78% | |
| ZOETIS INC CL A | 0.66% | |
| CARDINAL HEALTH INC | 0.66% | |
| CSL LTD COMMON STOCK | 0.63% | |
| EDWARDS LIFESCIENCES CORP | 0.61% | |
| Bayer Aktiengesellschaft | 0.60% | |
| LONZA GROUP -REG | 0.60% | |
| ARGENX SE | 0.59% | |
| IDEXX LABS INC | 0.59% | |
| BECTON DICKINSON and CO | 0.59% | |
| HALEON PLC | 0.58% | |
| BlackRock Cash Funds: Institutional, SL Agency Shares | 0.55% | |
| ALCON INC | 0.50% | |
| OTSUKA HOLDINGS | 0.48% | |
| UCB SA | 0.48% | |
| GALDERMA GRP. AG | 0.48% | |
| CHUGAI PHARMA CO | 0.47% | |
| SANDOZ GROUP AG | 0.46% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.